|
Editors-in-Chief
Seth P. Lerner, MD
Baylor College of Medicine
Scott Department of Urology
Houston, Texas, USA
Email: blc@iospress.com
Dan Theodorescu, MD, PhD
Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center
Los Angeles, California, USA
Email: blc@iospress.com
Associate Editors for Reviews
Andrea B. Apolo, MD
National Cancer Institute, US Department of Health and Human Services, Rockville, USA
Georgios Gakis, MD, PhD
University Hospital Würzburg, Department of Urology, Würzburg, Germany
Nathan Lawrentschuk, MD, PhD
University of Melbourne, Department of Surgery, Victoria, Australia
Associate Editor of Challenging Cases in Urothelial Cancer
Mark S. Soloway, MD
Memorial Healthcare System, Aventura, USA
Associate Editors of Clinical Trials Corner
Piyush K. Agarwal, MD
University of Chicago Medicine, Chicago, USA
Cora N. Sternberg, MD
Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, USA
Associate Editor of Paper Alert
Edward M. Messing, MD
University of Rochester Medical Center, Department of Urology, Rochester, USA
Social Media Associate Editor
Bishoy M. Faltas, MD
Weill Cornell Medicine, New York, USA
Assistant Social Media Editor
Kyrillus Shohdy, MD
Weill Cornell Medicine, New York, USA
Associate Editors
Joaquim Bellmunt, MD, PhD
Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, USA
David J. DeGraff, PhD
Pennsylvania State University College of Medicine, Department of Pathology, Hershey, USA
Lars Dyrskjøt, PhD
Aarhus University, Department of Molecular Medicine, Aarhus, Denmark
Jason A. Efstathiou, MD, DPhil
Massachusetts General Hospital, Harvard Medical School, Radiation Oncology, Boston, USA
Thomas Flaig, MD
University of Colorado, Division of Medical Oncology, Aurora, USA
Donna Hansel, MD, PhD
Oregon Health & Science University, Department of Pathology & Laboratory Medicine, Portland, USA
Arndt Hartmann, MD
University Erlangen-Nürnberg, Institute of Pathology, Erlangen, Germany
Anne Kiltie, MA, DM, DSc
University of Oxford, Department of Oncology, Oxford, United Kingdom
Yair Lotan, MD
UT Southwestern Medical Center, Urology Clinic, Dallas, USA
S. Bruce Malkowicz, MD
Hospital of the University of Pennsylvania, Philadelphia, USA
Surena F. Matin, MD
University of Texas MD Anderson Cancer Center, Department of Urology, Division of Surgery, Houston, USA
David McConkey, PhD
Johns Hopkins Greenberg Bladder Cancer Institute and Brady Urological Institute, Johns Hopkins University, Baltimore, USA
Matt Milowsky, MD
University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, USA
Francisco X. Real, MD, PhD
CNIO (Spanish National Cancer Research Centre), Molecular Oncology Programme, Madrid, Spain
Bas W.G. van Rhijn, MD, PhD
Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Gottfrid Sjödahl, Ph.D.
Lund University, Department of Translational Medicine, Lund, Sweden
George Thalmann, MD
University of Bern, Department of Urology, Bern, Switzerland
Xue-Ru Wu, MD
New York University (NYU), Department of Urology/Pathology, New York, USA
Diane Zipursky Quale, BA, JD
Bladder Cancer Advocacy Network (BCAN), Bethesda, USA
Alexandre R. Zlotta, MD, PhD
Sinai Health System, Uro-Oncology, Lunenfeld-Tanenbaum Research Institute, Toronto, Canada
Princess Margaret Cancer Centre, University Health Network, Department of Surgical Oncology, Urology, Toronto, Canada
|
Editorial Board
Cory Abate-Shen, PhD
Columbia University Medical Center, Department of Molecular Pharmacology and Therapeutics, New York, USA
Phillip Abbosh, MD, PhD
Fox Chase Cancer Center at Temple University Hospital, Molecular Therapeutics, Philadelphia, USA
Hikmat Al-Ahmadie, MD
Memorial Sloan-Kettering Cancer Center, Department of Pathology, New York, USA
Matthew L. Albert, MD, PhD
Institut Pasteur, Department of Immunology, Paris, France
Jessie Au, PharmD, PhD
Optimum Therapeutics, San Diego, USA
Marko Babjuk, MD
Motol University Hospital and 2nd Faculty of Medicine, Department of Urology, Prague, Czech Republic
Rick Bangs, MBA, PMP
Patient Advocate, Pittsford, USA
Trinity Bivalacqua, MD, PhD
Johns Hopkins Medicine, Department of Urology, Surgery and Oncology, Baltimore, USA
Peter Black, MD
University of British Columbia, Department of Urology, Vancouver, Canada
Bernard Bochner, MD
Memorial Sloan-Kettering Cancer Center, Department of Urology, Surgery and Oncology, New York, USA
James Catto, MD, PhD
The University of Sheffield, Academic Urology Unit, Sheffield, United Kingdom
Karim Chamie, MD
University of California Los Angeles, Department of Urology, Los Angeles, USA
Keith Syson Chan, PhD
Samuel Oschin Comprehensive Cancer Institute, Academic Pathology, Cedars-Sinai Medical Center, Los Angeles, USA
Sam S. Chang, MD
Vanderbilt University Medical Center, Department of Urology, Nashville, USA
Liang Cheng, MD
Indiana University, Department of Pathology & Laboratory Medicine, Indianapolis, USA
Richard J. Cote, MD
Washington University, Department of Pathology and Immunology, St Louis, USA
Bogdan Czerniak, MD, PhD
University of Texas MD Anderson Cancer Center, Department of Pathology, Houston, USA
Garrett M. Dancik, PhD
Eastern Connecticut State University, Department of Computer Science, Willimantic, USA
Siamak Daneshmand, MD
University of Southern California, Department of Urology, Los Angeles, USA
Ian D. Davis, MBBS (Hons), PhD, FRACP, FAChPM
Monash University and Eastern Health, Eastern Health Clinical School, Box Hill, Australia
Colin P.N. Dinney, MD
University of Texas MD Anderson Cancer Center, Department of Urology, Houston, USA
Matthew Galsky, MD
Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, USA
Scott M. Gilbert, MD
H. Lee Moffitt Cancer Center & Research Institute, Department of Urology, Tampa, USA
Peter J. Goebell, MD, PhD
Universitätsklinikum Erlangen, Department of Urology, Erlangen, Germany
John Gore, MD
University of Washington, Department of Urology, Seattle, USA
Noah Hahn, MD
Johns Hopkins University School of Medicine, Department of Oncology and Urology, Baltimore, USA
Richard Hautmann, MD
Universität Ulm, Department of Urology, Ulm, Germany
Jean Heather Hoffman-Censits, MD
Johns Hopkins University, Baltimore, USA
Jer-Tsong Hsieh, PhD
UT Southwestern Medical Center, Department of Urology, Dallas, USA
Molly A. Ingersoll, PhD
Institut Pasteur, Department of Immunology, Paris, France
Ashish M. Kamat, MD
University of Texas MD Anderson Cancer Center, Department of Urology, Division of Surgery, Houston, USA
Lawrence Karsh, MD, FACS
The Urology Center of Colorado, Department of Clinical Research, Denver, USA
Wassim Kassouf, MD
McGill University Health Center, Department of Urology, Montreal, Canada
Lambertus (Bart) Kiemeney, PhD
Radboud University Medical Center, Department of Health Evidence, Nijmegen, The Netherlands
William Kim, MD
University of North Carolina, Department of Medicine, Chapel Hill, USA
Deborah W. Knapp, DVM
Purdue University, Department of Veterinary Clinical Sciences, West Lafayette, USA
Margaret Knowles, PhD
Leeds Institute of Cancer & Pathology, Department of Experimental Oncology, Leeds, United Kingdom
Badrinath Konety, MD
University of Minnesota, Department of Urology, Minneapolis, USA
David J. Kwiatkowski, MD, PhD
Brigham and Women's Hospital, Harvard Medical School, Department of Medicine, Boston, USA
Donald Lamm, MD
University of Arizona, Department of Surgery, Phoenix, USA
David Latini, PhD
Baylor College of Medicine, Department of Urology, Houston, USA
Nathan Lawrentschuk, MD, PhD
University of Melbourne, Department of Surgery, Victoria, Australia
Cheryl Lee, MD
The Ohio State University Wexner Medical Center, Columbus, USA
Vinata Lokeshwar, PhD
Augusta University Medical College of Georgia, Department of Biochemistry and Molecular Biology, Augusta, USA
Nuria Malats, MD
CNIO (Spanish National Cancer Research Centre), Genetic and Molecular Epidemiology Group, Madrid, Spain
Kazumasa Matsumoto, MD
Kitasato University, Department of Urology, Kanagawa, Japan
James McKiernan, MD
Columbia University, Department of Urology, New York, USA
Reza Mehrazin, MD
The Mount Sinai Hospital, Department of Urology, New York, USA
Maxwell Meng, MD
University of California San Francisco, Department of Urology, San Francisco, USA
Timur Mitin, MD, PhD
Oregon Health and Science University, Portland, USA
Anirban P. Mitra, MD, PhD
University of Southern California, Institute of Urology, Los Angeles, USA
Ofer Nativ, MD
Bnai Zion Medical Center, Department of Urology, Haifa, Israel
Roman Nawroth, PhD
Klinikum rechts der Isar, Technical University of Munich, Department of Urology, Munich, Germany
Matthew Nielsen, MD
UNC School of Medicine, Department of Urology, Chapel Hill, USA
Hiroyuki Nishiyama, MD, PhD
University of Tsukuba, Department of Urology, Tsukuba, Japan
Michael A. O'Donnell, MD
University of Iowa Carver College of Medicine, Department of Urology, Iowa City, USA
Torben Ørntoft, MD
Aarhus University Hospital, Department of Clinical Medicine, Aarhus, Denmark
Joan Palou Redorta, MD, PhD
Universitat Autònoma de Barcelona, Fundació Puigvert, Department of Urology, Barcelona, Spain
Howard L. Parnes, MD
National Cancer Institute, NIH, Devision of Cancer Prevention, Bethesda, USA
Dan Petrylak, MD
Yale University, Department of Medical Oncology, New Haven, USA
Elizabeth R. Plimack, MD
Fox Chase Cancer Center, Department of Hematology/Oncology, Philadelphia, USA
Kamal Pohar, MD
Ohio State University, Department of Urology, Columbus, USA
Michael P. Porter, MD
University of Washington, Department of Urology, Seattle, USA
Ludmila Prokunina-Olsson, PhD
National Cancer Institute, Laboratory of Translational Genomics,Division of Cancer Epidemiology and Genetics, Bethesda, USA
Nagireddy Putluri, PhD
Baylor College of Medicine, Dept. of Molecular and Cellular Biology, Houston, USA
David Quinn, MBBS, PhD
University of Southern California, Norris Comprehensive Cancer Center, Department of Medicine, Los Angeles, USA
François Radvanyi, PhD
Institut Curie - UMR 144 - CNRS, Department of Cell Biology and Cancer, Paris, France
Derek Raghavan, MD, PhD
Levine Cancer Institute, Atrium Health, Charlotte, USA
Leonardo O Reis, MD, MSc, PhD
University of Campinas, Sao Paulo, Brazil
Cyrill Rentsch, MD, PhD
University Hospital Basel, Division of Urology, Basel, Switzerland
Jonathan Rosenberg, MD
Memorial Sloan-Kettering Cancer Center, Department of Medical Oncology, New York, USA
Arthur I. Sagalowsky, MD
UT Southwestern Medical Center, Department of Urology, Dallas, USA
Maria De Santis, MD
Charité University Hospital, Interdisciplinary GU Oncology, Department of Urology, Berlin, Germany
Marta Sánchez-Carbayo, PhD
University of the Basque Country, Department of Cancer Research, Bilbao, Spain
Bernd J. Schmitz-Dräger, MD, PhD
Friedrich-Alexander University, Department of Urology and Pediatric Urology, Erlangen, Germany
Mark P. Schoenberg, MD
The Albert Einstein College of Medicine & The Montefiore Medical Center, Department of Urology, New York, USA
John P. Sfakianos, MD
Assistant Professor, Urologic Oncology, Department of Urology, Icahn School of Medicine at Mount Sinai, New York, USA
Shahrokh F. Shariat, MD, PhD
Medical University Vienna, Department of Urology, Vienna, Austria
Padmanee Sharma, MD, PhD
University of Texas MD Anderson Cancer Center, Department of Genitourinary Medical Oncology and Immunology, Houston, USA
Eila C. Skinner, MD
Stanford University, Department of Urology, Stanford, USA
Angela B. Smith, MD
UNC-Chapel Hill School of Medicine, Department of Urology, Chapel Hill, USA
Carolyn L. Smith, PhD
Baylor College of Medicine, Molecular & Cellular Biology, Houston, USA
Norm Smith, MD
Northshore University HealthSystem, Chicago, USA
Steven Christopher Smith, MD, PhD
Virginia Commonwealth University, School of Medicine, Richmond, USA
Walter Stadler, MD, FACP
University of Chicago, Comprehensive Cancer Center, Chicago, USA
Gary Steinberg, MD
NYU Langone Health, Department of Urology, New York, USA
Arnulf Stenzl, MD
Universitätsklinikum Tübingen, Department of Urology, Tübingen, Germany
Seth Strope, MD
Baptist MD Anderson Cancer Center, Jacksonville, Florida, USA
Hyun Hwan Sung, MD, PhD
Samsung Medical Center, Department of Urology, Seoul, Korea
Robert Svatek, MD, MSCI
UT Health Science Center San Antonio, Department of Urology, San Antonio, USA
John A. Taylor, III, MD, MS
University of Kansas Medical Center, Department of Urology, Kansas City, USA
Jennifer M. Taylor, MD, MPH
Baylor College of Medicine/DeBakey VAMC Houston, USA
Antonia Vlahou, PhD
Biomedical Research Foundation Academy of Athens, Department of Systems Biology, Athens, Greece
Nicholas Vogelzang, MD, FASCO
Comprehensive Cancer Centers of Nevada, Department of Medical Oncology, Las Vegas, USA
J. Alfred Witjes, MD, PhD
Radboud University Nijmegen, Department of Urology, Nijmegen, The Netherlands
Statistical and Bioinformatics Editorial Board
Debashis Ghosh, PhD
University of Colorado, Department of Biostatistics and Informatics, Aurora, USA
Susan Groshen, PhD
University of Southern California, Department of Preventive Medicine, Los Angeles, USA
Michael C. Sachs, PhD
Karolinska Institute, Department of Medical Epidemiology and Biostatistics, Stockholm, Sweden
Richard Sylvester, ScD
EORTC, Brussels, Belgium
Jeremy Taylor, PhD
University of Michigan, Department of Biostatistics, Ann Arbor, USA
|
